Twenty-seven states and the District of Columbia sued in federal court to block the sale in June, even though the pharmaceutical company promised to adhere to 23andMe's existing privacy policy ...

A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, according to a June 27 filing in the bankruptcy docket.

Anne Wojcicki's nonprofit TTAM acquires 23andMe for $305 million, ending the gene-testing pioneer's bankruptcy saga. The deal still faces state regulators' objections over genetic data control.

A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, according to a June 27 filing in the bankruptcy docket.

Thanks for signing up! Watch for us in your inbox. Subscribe Now 8 on Your Side Now, the case has taken another twist. A bankruptcy judge has approved the sale of 23andMe to a new buyer, TTAM ...

A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, according to a June 27 filing in the bankruptcy docket.

And in a memorandum opinion outlining his approval 23andMe’s sale to TTAM on Friday, Walsh acknowledged these states’ objections to the acquisition — but that noted many had since been resolved.

Our Litigators of the Week ushered through the $305 million bankruptcy sale of genetic testing company 23andMe to a newly formed nonprofit led by the company’s co-founder, Anne Wojcicki. A team ...

As a result, 23andMe closed on the court approved transaction. TTAM Research Institute, formed by 23andMe’s co-founder and former CEO Anne Wojcicki, is now the new owner of substantially all of ...